Terms: = Thyroid cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3 AND Diagnosis
48 results:
1. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
2. Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer D; Phay JE; Holt S; O'Donnell B; Nguyen J; Joseph D; Chi A; Wu S; Hao Y; Huang J; Klopper JP; Kloos RT; Kennedy GC; Shin J
Front Endocrinol (Lausanne); 2022; 13():1073592. PubMed ID: 36619548
[TBL] [Abstract] [Full Text] [Related]
3. Prospects of Testing Diurnal Profiles of Expressions of TSH-R and Circadian Clock Genes in Thyrocytes for Identification of Preoperative Biomarkers for thyroid Carcinoma.
Putilov A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293065
[TBL] [Abstract] [Full Text] [Related]
4. Sinomenine Hydrochloride Promotes tshr-Dependent Redifferentiation in Papillary thyroid cancer.
Zhang J; Zhao A; Jia X; Li X; Liang Y; Liu Y; Xie X; Qu X; Wang Q; Zhang Y; Gao R; Yu Y; Yang A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142613
[TBL] [Abstract] [Full Text] [Related]
5. Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
Liang MX; Fei YJ; Yang K; Tang WJ; Cao XH; Tang JH
BMC Cancer; 2022 Sep; 22(1):954. PubMed ID: 36064384
[TBL] [Abstract] [Full Text] [Related]
6. Indeterminate thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of the Molecular Landscape of Pediatric thyroid Nodules and Use of a Multigene Genomic Classifier in Children.
Gallant JN; Chen SC; Ortega CA; Rohde SL; Belcher RH; Netterville JL; Baregamian N; Wang H; Liang J; Ye F; Nikiforov YE; Nikiforova MN; Weiss VL
JAMA Oncol; 2022 Sep; 8(9):1323-1327. PubMed ID: 35679040
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation of benign thyroid nodules from malignant thyroid nodules through miR-205-5p and thyroid-stimulating hormone receptor mRNA.
Zhou J; Cao L; Chen Z
Hormones (Athens); 2021 Sep; 20(3):571-580. PubMed ID: 33788150
[TBL] [Abstract] [Full Text] [Related]
9. Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation.
Gilani SM; Ross JA; Prasad ML; Hammers L; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):363-373. PubMed ID: 33045146
[TBL] [Abstract] [Full Text] [Related]
10. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract] [Full Text] [Related]
11. Association between tshr gene methylation and papillary thyroid cancer: a meta-analysis.
Qu M; Wan S; Ren B; Wu H; Liu L; Shen H
Endocrine; 2020 Sep; 69(3):508-515. PubMed ID: 32279226
[TBL] [Abstract] [Full Text] [Related]
12. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
13. Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the diagnosis of Papillary thyroid cancer.
Kocsis-Deák B; Árvai K; Balla B; Tóbiás B; Kohánka A; Járay B; Horányi J; Podani J; Takács I; Putz Z; Kósa J; Lakatos P
Pathol Oncol Res; 2020 Jan; 26(1):101-108. PubMed ID: 31758407
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive Genetic Analysis of Follicular thyroid Carcinoma Predicts Prognosis Independent of Histology.
Nicolson NG; Murtha TD; Dong W; Paulsson JO; Choi J; Barbieri AL; Brown TC; Kunstman JW; Larsson C; Prasad ML; Korah R; Lifton RP; Juhlin CC; Carling T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2640-2650. PubMed ID: 29726952
[TBL] [Abstract] [Full Text] [Related]
15. Methylation markers differentiate thyroid cancer from benign nodules.
Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
[TBL] [Abstract] [Full Text] [Related]
16. Circulating thyroid cancer biomarkers: Current limitations and future prospects.
Nixon AM; Provatopoulou X; Kalogera E; Zografos GN; Gounaris A
Clin Endocrinol (Oxf); 2017 Aug; 87(2):117-126. PubMed ID: 28493290
[TBL] [Abstract] [Full Text] [Related]
17. Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.
Zhang ZZ; Chen Q; Kong CY; Li ZM; Wang LS
Oncotarget; 2017 Jan; 8(4):6623-6629. PubMed ID: 28036261
[TBL] [Abstract] [Full Text] [Related]
18. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
[TBL] [Abstract] [Full Text] [Related]
19. Interaction of Age at diagnosis with Transcriptional Profiling in Papillary thyroid cancer.
Hsu YC; Liu CL; Yang PS; Tsai CH; Lee JJ; Cheng SP
World J Surg; 2016 Dec; 40(12):2922-2929. PubMed ID: 27384173
[TBL] [Abstract] [Full Text] [Related]
20. Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.
Sitasuwan T; Hanamornroongruang S; Peerapatdit T; Thongtang N
BMC Endocr Disord; 2015 Nov; 15():68. PubMed ID: 26530865
[TBL] [Abstract] [Full Text] [Related]
[Next]
